GALECTIN THERAPEUTICS INC 4
4 · GALECTIN THERAPEUTICS INC · Filed Jul 8, 2015
Insider Transaction Report
Form 4
Prelack Steven
Director
Transactions
- Award
Common Stock
2015-04-08+2,259→ 16,307 total - Disposition to Issuer
Stock Option (right to buy)
2015-04-08−16,714→ 0 totalExercise: $3.59Exp: 2023-03-28→ Common Stock (16,714 underlying) - Award
Common Stock
2015-04-08+90,882→ 107,189 total - Award
Common Stock
2015-03-12+11,112→ 14,048 total - Disposition to Issuer
Stock Option (right to buy)
2015-04-08−6,168→ 0 totalExercise: $7.08Exp: 2021-06-28→ Common Stock (6,168 underlying)
Footnotes (3)
- [F1]The option vested as to one-eighth of the shares on June 28, 2011 and thereafter quarterly in seven equal installments beginning August 12, 2011.
- [F2]The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 19,504 shares of restricted common stock, reported in Table 1 of this Form 4 as a part of the April 8, 2015 grant of 90,882 shares, as consideration for the cancellation of options granted on June 28, 2011 and March 28, 2013.
- [F3]The option vested quarterly in eight equal installments beginning on May 12, 2013.